Early screening opportunities for IRDs
Inherited retinal diseases (IRDs) are a group of clinically and genetically heterogeneous diseases, which cause visual loss due to improper development or premature death of the retinal photoreceptors. IRDs affect individuals of all ages, with different IRDs progressing at different rates. Many IRDs are degenerative, getting worse over time and causing severe vision loss or even blindness.
The ISCEV Guide to Electrodiagnostic Procedures advises using electrophysiology (ERG, mfERG, PERG, PhNR, EOG) responses are objective measures of retinal function and assist in accurately differentiating between IRDs as well as judging the severity of the specific IRD. The information from these tests can also assist with counseling and developing life management skills. In addition, ERG and the psychophysical tests (DA and FST) assist with gene therapy trials that may improve outcomes for people born with an IRD.
Visual electrophysiology for IRDs
Bestrophinopathies
Bestrophinopathies are a recognizable phenotype of degenerative eye diseases caused by inherited mutations in the BEST1 gene. BEST1 mutations may also play a role in other ophthalmic diseases like rod-cone dystrophy and early-onset cataracts. Bestrophinopathies are characterized by abnormal ocular development, which leads to impaired function in the retinal pigment epithelium (RPE) layer resulting in yellowish sub-retinal lesions.
All bestrophinopathies are characterized by a decreased electrooculogram (EOG) Arden ratio (light peak/dark trough). Both full-field ERG (ffERG) and multifocal ERG (mfERG) can assist in differentiating within the phenotype as well as tracking the progression of the condition.
Congenital Achromatopsia
Congenital Achromatopsia is a hereditary vision disorder characterized by lack of cone vision due to malfunction of the retinal phototransduction pathway. The cone photoreceptors are unable to properly respond to a light stimulus. People with achromatopsia are partially or totally color blind. They also have poor visual acuity, photophobia, and pendular nystagmus. Currently, there are four known gene mutations that cause this disorder. There are two subtypes in this condition and both types have abnormal ERG recordings with preservation of the rod-mediated ERG. Patients with the more severe subtype show nondetectable cone function in an ERG test while patients with the less severe subtype show some residual cone function. Gene therapy studies of animal models of human achromatopsia have had some success in recovering cone function.
Congenital Stationary Night Blindness
Congenital Stationary Night Blindness (CSNB) is a clinically and genetically heterogeneous group of hereditary retinal disorders primarily affecting the photoreceptors, although the retinal pigment epithelium and the bipolar cells may also be affected. Types within this group differ in electrophysiological characteristics as well as fundus appearance and mode of inheritance. The full-field ERG can assist in diagnosing different forms of CSNB.
Leber Congenital Amaurosis
Leber Congenital Amaurosis (LCA) is a group of hereditary retinal diseases causing the most severe form of IRD in which both rods and cones are either nonfunctional at birth or are lost within the first years of life. It is also the most common cause of inherited blindness in children.
LCA is characterized by a severely reduced or non-detectable scotopic and photopic ERG response. DiagnosysFST® was used in the first-ever successful gene therapy drug trial for (LUXTURNA™) by Spark Therapeutics. DiagnosysFST® is now used clinically for the assessment of vision pre and post LUXTURNA™ treatment.
Leber’s Hereditary Optic Neuropathy
Leber Hereditary Optic Neuropathy (LHON) is a common inherited mitochondrial disorder and typically affects young males more than females. The disorder leads to degeneration of the retinal ganglion cells with painless sub-acute central vision loss in one or both eyes during the young adult years.
Studies show that the PhNR amplitude is significantly decreased in people with LHON and can distinguish carriers from controls. Treatment options are limited but include the use of antioxidant supplements. Gene therapy trials are currently underway.
Retinitis Pigmentosa
Retinitis Pigmentosa (RP), also known as rod-cone degeneration, is the most common form of IRD. RP is a group of eye disorders that causes progressive vision loss as the rod photoreceptors degenerate in the early stages of the disease, followed by cone cell death.
Full-field electroretinograms (ERGs) are valuable in diagnosing early-stage retinitis pigmentosa (RP), often detecting the condition before any fundus abnormalities become visible through ophthalmoscopy. Dark adaptation is typically prolonged; therefore, dark adaptometry (DA) can also be helpful in identifying early cases of the disease.
Stargardt Disease
Stargardt Disease is a common form of inherited macular degeneration. Electroretinograms (ERGs) provide useful information to assist in counseling and life management skills. Research is ongoing to help minimize vision loss due to this condition. ERGs and psychophysical tests are also being used in clinical trials for this condition.
Usher Syndrome
Usher Syndrome causes combined progressive hearing and vision loss. Newborns often have moderate to severe hearing impairment while symptoms of retinitis pigementosa (RP) start shortly after adolescence.
Full-field electroretinograms (ERGs) aid in the early diagnosis of retinitis pigmentosa (RP), often identifying the condition before any visible fundus abnormalities can be detected with an ophthalmoscope. Dark adaptometry (DA) can also be valuable in early detection, as RP typically causes prolonged dark adaptation.
X-linked Retinoschisis
X-linked Retinoschisis (XLRS) is an inherited disease caused by mutations in the Retinoschisin 1 gene that causes loss of central and peripheral vision characterized by abnormal splitting within the inner retinal layers.
The full-field ERG is useful in diagnosing X-linked retinoschisis (XLRS), as patients often show a reduced b-wave with a preserved a-wave under dark-adapted conditions, called an electronegative response. Meanwhile, full-field stimulus threshold (FST) testing is typically normal or near normal in XLRS. These functional tests offer valuable insights into XLRS abnormalities and may aid in future clinical trials.
References
Arden GB, Carter RM, Hogg CR, Powell DJ, Ernst WJ, Clover GM, Lyness AL, Quinlan MP. Rod and cone activity in patients with dominantly inherited retinitis pigmentosa: comparisons between psychophysical and electroretinographic measurements. Br J Ophthalmol. 1983 Jul;67(7):405-18. doi: 10.1136/bjo.67.7.405. PMID: 6860608; PMCID: PMC1040089.
Boon CJ, van den Born LI, Visser L, Keunen JE, Bergen AA, Booij JC, Riemslag FC, Florijn RJ, van Schooneveld MJ. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology. 2013 Apr;120(4):809-20. doi: 10.1016/j.ophtha.2012.09.057. Epub 2013 Jan 3. PMID: 23290749.
Chao DL, Burr A, Pennesi M. RPE65-Related Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy. 2019 Nov 14. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 31725251.
Fujinami K, Lois N, Davidson AE, Mackay DS, Hogg CR, Stone EM, Tsunoda K, Tsubota K, Bunce C, Robson AG, Moore AT, Webster AR, Holder GE, Michaelides M. A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13. doi: 10.1016/j.ajo.2013.01.018. Epub 2013 Mar 15. PMID: 23499370.
Karanjia R, Berezovsky A, Sacai PY, Cavascan NN, Liu HY, Nazarali S, Moraes-Filho MN, Anderson K, Tran JS, Watanabe SE, Moraes MN, Sadun F, DeNegri AM, Barboni P, do Val Ferreira Ramos C, La Morgia C, Carelli V, Belfort R Jr, Coupland SG, Salomao SR, Sadun AA. The Photopic Negative Response: An Objective Measure of Retinal Ganglion Cell Function in Patients With Leber’s Hereditary Optic Neuropathy. Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO300-BIO306. doi: 10.1167/iovs.17-21773. PMID: 29049835.
Genead MA, Fishman GA, Rha J, Dubis AM, Bonci DM, Dubra A, Stone EM, Neitz M, Carroll J. Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7298-308. doi: 10.1167/iovs.11-7762. PMID: 21778272; PMCID: PMC3183969.
McAnany JJ, Park JC, Fishman GA, Collison FT. Full-Field Electroretinography, Pupillometry, and Luminance Thresholds in X-Linked Retinoschisis. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):53. doi: 10.1167/iovs.61.6.53. PMID: 32579680; PMCID: PMC7416904.
Prokofyeva E, Troeger E, Zrenner E. The special electrophysiological signs of inherited retinal dystrophies. Open Ophthalmol J. 2012;6:86-97. doi: 10.2174/1874364101206010086. Epub 2012 Oct 31. PMID: 23166577; PMCID: PMC3496915.
Sergouniotis PI, Robson AG, Li Z, Devery S, Holder GE, Moore AT, Webster AR. A phenotypic study of congenital stationary night blindness (CSNB) associated with mutations in the GRM6 gene. Acta Ophthalmol. 2012 May;90(3):e192-7. doi: 10.1111/j.1755-3768.2011.02267.x. Epub 2011 Oct 19. PMID: 22008250.
Stingl K, Kurtenbach A, Hahn G, Kernstock C, Hipp S, Zobor D, Kohl S, Bonnet C, Mohand-Saïd S, Audo I, Fakin A, Hawlina M, Testa F, Simonelli F, Petit C, Sahel JA, Zrenner E. Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study. Doc Ophthalmol. 2019 Oct;139(2):151-160. doi: 10.1007/s10633-019-09704-8. Epub 2019 Jul 2. PMID: 31267413.